The Impact of 'A Miss Is as Good as a Mile': Is Compensation Necessary for Minimal Ocular Deviation in Myopic Laser Surgery?

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University

About this trial

The goal of this clinical trial is to evaluate the effect of intraoperative kappa-angle compensation on postoperative visual quality in patients undergoing small incision lenticule extraction (SMILE) using the VisuMax 800 platform. The study will enroll patients with myopia and a kappa-angle offset \< 0.2 mm.

The main questions it aims to answer are:

Does intraoperative kappa-angle compensation reduce postoperative higher-order aberrations after SMILE? Does kappa-angle compensation improve postoperative visual quality and refractive outcomes compared with no compensation?

Researchers will compare SMILE with intraoperative kappa-angle compensation to SMILE without compensation to determine whether compensation leads to better optical quality and visual performance.

Participants will:

Undergo SMILE surgery with or without intraoperative kappa-angle compensation Complete scheduled postoperative examinations at 1 week, 1 month, 3 months, and 6 months after surgery Receive measurements of visual acuity, refraction, higher-order aberrations, contrast sensitivity, and safety outcomes

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18 to 40 years with myopia or myopic astigmatism and stable refraction for >=1 year, whose refractive errors fall within the treatable range of and meet the indications for SMILE surgery.

Normal corneal morphology and corneal thickness meeting surgical requirements.

Preoperative corrected distance visual acuity (CDVA) >= 1.0.

Preoperative synthetic Kappa angle offset measured >= 0.10 mm and < 0.20 mm.

Disqualifiers

History of prior ocular surgery, significant ocular trauma, or presence of corneal or ocular diseases that may affect the safety of refractive surgery.

Severe systemic diseases that may affect ocular healing or surgical safety.

Females who are pregnant or lactating.

Inability to cooperate as required to complete the procedure or follow-up visits.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Apply compensation to the Kappa angle.

    Procedure/Surgery

    SMILE PRO is an upgraded version/procedural designation of SMILE (Small Incision Lenticule Extraction) performed on the ZEISS VisuMax 800 femtosecond laser platform and remains, in essence, an all-femtosecond corneal refractive procedure. Its basic principle is to use a femtosecond laser to create a lenticule within the corneal stroma together with a small incision, and then remove the lenticule through that incision, thereby reshaping the corneal curvature to correct myopia and astigmatism. In the compensation group, during preoperative parameter input, a fixed intraoperative laser centration compensation of 0.1 mm was uniformly applied to all study eyes meeting the inclusion criteria to achieve a quantitative adjustment of the treatment center toward the visual axis.

  • Apply no compensation to the Kappa angle

    Procedure/Surgery

    SMILE PRO is an upgraded version/procedural designation of SMILE (Small Incision Lenticule Extraction) performed on the ZEISS VisuMax 800 femtosecond laser platform and remains, in essence, an all-femtosecond corneal refractive procedure. Its basic principle is to use a femtosecond laser to create a lenticule within the corneal stroma together with a small incision, and then remove the lenticule through that incision, thereby reshaping the corneal curvature to correct myopia and astigmatism. In the non-compensation group, no kappa-angle-based laser centration compensation was applied intraoperatively, and the treatment center was set according to the system's default centration method.

Treatment groups

224 Participants
are divided into 2 treatment groups
Group A: Non-compensation groupActive comparator 1 intervention
Group B: Compensation groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Coma aberration

Coma aberration measured by wavefront aberrometry to evaluate the effect of intraoperative kappa-angle compensation on postoperative optical quality.

Time frame
3 months after surgery

Secondary outcomes

1

Higher-order aberrations

Total higher-order aberrations, spherical aberration, and trefoil aberration measured using wavefront aberrometry under standardized conditions to evaluate postoperative optical quality.

Time frame
1 month, 3 months, and 6 months after surgery
2

Optical zone decentration

Decentration of the optical zone measured using corneal topography by determining the displacement between the optical zone center and the corneal vertex.

Time frame
3 months after surgery
3

Visual acuity

Binocular uncorrected distance visual acuity and corrected distance visual acuity measured using standardized visual acuity charts to evaluate visual performance and safety.

Time frame
1 month, 3 months, and 6 months after surgery
4

Manifest refraction

Postoperative sphere, cylinder, and spherical equivalent measured by manifest refraction.

Time frame
1 month, 3 months, and 6 months after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.